EdwardAllenNeuweltMD
Neurosurgery • Portland, ORProfessor of Neurological Surgery, Oregon Hlth & Sci Univ
Are you Dr. Neuwelt?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 39 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3181 Sw Sam Jackson Park Rd
L603
Portland, OR 97239Phone+1 503-494-5626- Is this information wrong?
Summary
- Dr. Edward Neuwelt, MD is a neurosurgeon in Portland, Oregon. He is currently licensed to practice medicine in Oregon, Maryland, and Texas. He is affiliated with OHSU Hospital and Portland HCS.
Education & Training
University of Texas Southwestern Medical CenterResidency, Neurological Surgery, 1976 - 1978
University of MarylandResidency, Internal Medicine, 1974 - 1975- University of Texas Southwestern Medical CenterResidency, Neurological Surgery, 1973 - 1974
- University of Texas Southwestern Medical Center/Parkland Memorial HospitalInternship, Transitional Year, 1972 - 1973
University of Colorado School of Medicine Anschutz Medical CampusClass of 1972
Certifications & Licensure
OR State Medical License 1981 - 2021
TX State Medical License 1973 - 1987
MD State Medical License 1975 - 1981
CO State Medical License 1973 - 1977- American Board of Neurological Surgery Neurological Surgery
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2009-2014
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
- Portland Monthly Magazine Castle Connolly, 2011
- Join now to see all
Clinical Trials
- Treating Patients With Recurrent PCNSL With Carboplatin/BBBD and Adding Rituxan To The Treatment Regimen Start of enrollment: 2003 Jan 01
- Methotrexate, Cyclophosphamide, and Etoposide Phosphate Given With Osmotic Blood-Brain Barrier Disruption Plus Dexamethasone and Cytarabine in Treating Patients With Primary CNS Lymphoma Start of enrollment: 2000 Jan 01
- Methotrexate, Procarbazine, Lomustine, Dexamethasone, and Cytarabine in Treating Patients With Primary CNS Lymphoma Start of enrollment: 2000 Jan 01
- Join now to see all
Publications & Presentations
PubMed
- Deciphering spatially distinct immune microenvironments in glioblastoma using ferumoxytol and gadolinium-enhanced and FLAIR hyperintense MRI phenotypes.Stoller, J., Muldoon, L., Harrington, C., Fu, R., Barajas, R., Kersch, C., Ambady, P., Raslan, A., Dogan, A., Neuwelt, E.> ;Neuro-Oncology Advances. 2023 Nov 8
- 3 citationsIntravenous N-Acetylcysteine to Prevent Cisplatin-Induced Hearing Loss in Children: A Nonrandomized Controlled Phase I Trial.Etan Orgel, Kristin R Knight, Yueh-Yun Chi, Jemily Malvar, Teresa Rushing, Victoria Mena, Laurie S Eisenberg, Shahrad R Rassekh, Colin J D Ross, Erika N Scott, Michael...> ;Clinical Cancer Research. 2023 Jul 5
- 7 citationsPharmacological reduction of coagulation factor XI reduces macrophage accumulation and accelerates deep vein thrombosis resolution in a mouse model of venous thrombosis.Kelley R Jordan, Cory R Wyatt, Meghan E Fallon, Randy Woltjer, Edward A Neuwelt, Quifang Cheng, David Gailani, Christina Lorentz, Erik I Tucker, Owen J T McCarty, Moni...> ;Journal of Thrombosis and Haemostasis. 2022 Sep 1
- Join now to see all
Press Mentions
Driven by OHSU Research, FDA Approves New Drug to Prevent Hearing Loss in Children with CancerJanuary 17th, 2023- Tough Choices: Chemo That Can Save Kids with Cancer Can Also Damage HearingSeptember 28th, 2021
OHSU School of Medicine Researchers Teach High School Students to Be ScientistsDecember 10th, 2019- Join now to see all
Grant Support
- Delivery Issues In Lung Cancer CNS MetastasesVeterans Affairs2012
- Opening Of The Blood-Brain Barrier To Antitumor AgentsNational Institute Of Neurological Disorders And Stroke2010–2012
- The Annual Blood-Brain Barrier Consortium MeetingNational Cancer Institute2006–2012
- The Annual Blood-Brain Barrier Consortium MeetingNational Institute Of Neurological Disorders And Stroke2011
- Two Compartment Models To Improve Brain Tumor TherapyNational Cancer Institute2008–2011
- Nanoparticle MR Imaging Of BBB Inflammation At High Tesla In CNS TumorsNational Institute Of Neurological Disorders And Stroke2007–2011
- Opening Of The Blood Brain Barrier To Antitumor AgentsNational Institute Of Neurological Disorders And Stroke2002–2008
- CNS Gene Delivery And Imaging In Brain Tumor TherapyNational Institute Of Neurological Disorders And Stroke2003–2007
- Two Compartment Models To Improve Brain Tumor TherapyNational Institute Of Neurological Disorders And Stroke1999–2007
- Ferumoxytol And TumorsNational Center For Research Resources2005
- Annual Blood-Brain Barrier Consortium MeetingNational Cancer Institute2005
- MR, Histologic And EM Imaging Of Intravenous Particles To Brain TumorsNational Center For Research Resources2004–2005
- The Annual Blood Brain Barrier Consortium MeetingNational Cancer Institute2000–2004
- CNS Gene Delivery And Efficacy In Brain Tumor TherapyNational Institute Of Neurological Disorders And Stroke1996–2001
- Opening Of The Blood-Brain Barrier To Antitumor AgentsNational Cancer Institute1994–2001
- Delivery Of Diagnostic And Therapeutic Mabs To CNSNational Institute Of Neurological Disorders And Stroke1995–1998
- Opening The Blood-Brain Barrier To Antitumor AgentsNational Cancer Institute1993
- Pathogenesis And Gene Therapy In Gm2-GangliosidosisNational Institute Of Neurological Disorders And Stroke1990–1992
- Osmotic Opening Of The Blood-Brain BarrierNational Cancer Institute1988–1992
- Osmotic Opening Of The BBB To Anti-Tumor AgentsNational Cancer Institute1985–1988
Professional Memberships
- Member
- Member
- Fellow
Hospital Affiliations
Portland HCSPortland, Oregon
OHSU HospitalPortland, Oregon
